Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP-001 in Adult Patients With Growth Hormone Deficiency
NCT01247675Phase 2Completed
- Sponsor
- Ascendis Pharma
- Start
- Nov 2010
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ACP-001 in growth hormone deficiency (GHD), sponsored by Ascendis Pharma. Started Nov 2010; status: completed.
02
Drugs
ACP-001
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01247675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247675.